Page last updated: 2024-08-26

sr141716 and Necrosis

sr141716 has been researched along with Necrosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernardi, M; Caraceni, P; Croci, T; Cutrin, J; Domenicali, M; Giannone, F; Grattagliano, I; Mastroleo, C; Perrelli, MG; Pertosa, AM; Principe, A; Trevisani, F	1

Other Studies

1 other study(ies) available for sr141716 and Necrosis

Article	Year
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia. Gut, 2009, Volume: 58, Issue:8 Topics: Alanine Transaminase; Animals; Blood Pressure; Drug Evaluation, Preclinical; Endotoxemia; Lipopolysaccharides; Liver; Liver Circulation; Male; Necrosis; Neutrophil Infiltration; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reperfusion Injury; Rimonabant	2009

Article

Year

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia.

Gut, 2009, Volume: 58, Issue:8

Topics: Alanine Transaminase; Animals; Blood Pressure; Drug Evaluation, Preclinical; Endotoxemia; Lipopolysaccharides; Liver; Liver Circulation; Male; Necrosis; Neutrophil Infiltration; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reperfusion Injury; Rimonabant

2009